Delivery Order SPE2DR25D9305-SPE2DR26FSHB7
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $34,224.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. The award was issued on October 27, 2025, with an ultimate completion date of November 18, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,494.86 to DMS Pharmaceutical Group Inc. for EYLEA 2mg/0.05mL syringes on December 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through a firm fixed-price contract type with no set-aside designation. The delivery order represents a single transaction issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,110.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 ml vials. The delivery order was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, and utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. is performing the work at its Park...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $5,027.08 to DMS Pharmaceutical Group Inc. for EYLEA 2 mg/0.05 mL vials on October 29, 2025, with completion scheduled for November 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation. This delivery order represents one of numerous purchases issued to the...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency (DLA) awarded a $24,948.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EYLEA 2 mg/0.05 mL syringes. This delivery order, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, contains no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The award is issued under DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,513.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The award, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is...
- The U.S. Defense Logistics Agency has awarded a firm fixed-price delivery order contract worth $12,919.30 to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML syringes, and has a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, that DMS Pharmaceutical Group holds with the Defense Logistics Agency. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,919.30, is for the delivery of EYLEA 2 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to...
- SPE2DR25D9305Indefinite Delivery Contract
- SPE2DR25D9305-SPE2DR26FSHB7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,363.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. The contract, issued on January 12, 2026, with an ultimate completion date of February 3, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued against DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for military healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through its established performance on numerous delivery orders issued by the DLA's Medical Supply Chain division. As one of multiple regional prime vendor contractors under the PPV-G GEN V program, the company is authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. The IDC, awarded in November 2025 with a $499,999,999 ceiling value and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, with the current delivery order representing routine medical supply fulfillment for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 1/11/26 |